AlTi Global, Inc. Class A Common Stock (ALTI)
AlTi Global, Inc. Class A (ALTI) is an investment firm focused on acquiring and managing private equity assets, including aerospace, defense, and related technology companies. The company emphasizes long-term value creation through strategic investments in innovative businesses within its targeted sectors.
Company News
AlTi Global, Inc. (ALTI) delivered earnings and revenue surprises of -66.67% and 17.38%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NASDAQ: ELVN) rose sharply during Thursday’s session. Enliven Therapeutics announced proof of concept data from Phase 1 clinical trial of ELVN-001 in chronic myeloid leukemia. Enliven Therapeutics shares surged 26% to $24.97 on Thursday. Here are some other big stocks recording losses in today’s session. Rallybio Corporation (NASDAQ: RLYB) shares gained 89.6% to $3.09 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT. Alpine Immune Sciences, ...